ArTara Therapeutics, Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2017 | $4 M | No. 1 | $2 to $10 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
ArTara Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2018).
SEC Form D · Jan 2018
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jan 2018
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of ArTara Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Smith | Executive officer | Jan 2018 |
| Jesse Shefferman | Executive officer | Jan 2018 |
| Randall Marshall | Executive officer | Jan 2018 |
| Jesse Shefferman | Director | Jan 2018 |
| Randall Marshall | Director | Jan 2018 |